Yoshimichi Miyashiro Selected Research

Diiodotyrosine

1/2022

Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshimichi Miyashiro Research Topics

Disease

6	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2010
2	Alopecia (Baldness) 12/2021 - 12/2020
1	Graves Disease (Basedow Disease) 01/2022
1	Thyroiditis 01/2022
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 09/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 04/2016
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2010

Drug/Important Bio-Agent (IBA)

6	AndrogensIBA 01/2018 - 11/2010
3	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 11/2010
2	SteroidsIBA 12/2021 - 12/2020
2	Hormones (Hormone)IBA 12/2021 - 12/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 11/2010
2	Dihydrotestosterone (Androstanolone)IBA 01/2016 - 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	MonoiodotyrosineIBA 01/2022
1	DiiodotyrosineIBA 01/2022
1	Amino Acids FDA Link 09/2021
1	Progestins (Progestagens)IBA 01/2018
1	CarbonIBA 01/2018
1	abirateroneIBA 01/2016
1	EnzymesIBA 01/2013
1	androstaneIBA 01/2013
1	trilostane FDA Link 11/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2010

Therapy/Procedure

3	Castration 01/2016 - 02/2011
2	Therapeutics 01/2018 - 01/2013